おすすめの製品
品質水準
保管温度
−20°C
関連するカテゴリー
アプリケーション
About Targeted NanoFabTx™
Targeted NanoFabTX™- PEG-RGD Lipid Mix; for synthesis of PEGylated RGD targeted liposomes is a ready-to-use nanoformulation lipid blend that includes lyophilized lipids and step-by-step instructions for synthesizing PEG-RGD targeted liposomes for the targeted delivery of the API to cancer cells.
Lipid-based formulations are widely used for drug delivery and enable improved therapeutic efficacy of a range of drug types including small molecules, nucleic acids, proteins and peptides. This optimized lipid blend containg RGD peptide for targeted drug delivery and PEG to improve circulation time and impose stealth like behavior.
Application example:
Integrins (alpha V beta 3) are overexpressed by many cancer cells. The RGD peptide has high affinity to the integrins. Thus, liposomes containing the ligand RGD can be used to deliver the anti-cancer agent directly to the cancer cells. The targeted RGD liposomes will deliver the API to only the cancer cells and not the healthy cells. As a result, the targeted liposomes avoid off target effects which is a side effect of many anti-cancer therapies.
Targeted NanoFabTX™- PEG-RGD Lipid Mix; for synthesis of PEGylated RGD targeted liposomes is a ready-to-use nanoformulation lipid blend that includes lyophilized lipids and step-by-step instructions for synthesizing PEG-RGD targeted liposomes for the targeted delivery of the API to cancer cells.
Lipid-based formulations are widely used for drug delivery and enable improved therapeutic efficacy of a range of drug types including small molecules, nucleic acids, proteins and peptides. This optimized lipid blend containg RGD peptide for targeted drug delivery and PEG to improve circulation time and impose stealth like behavior.
Application example:
Integrins (alpha V beta 3) are overexpressed by many cancer cells. The RGD peptide has high affinity to the integrins. Thus, liposomes containing the ligand RGD can be used to deliver the anti-cancer agent directly to the cancer cells. The targeted RGD liposomes will deliver the API to only the cancer cells and not the healthy cells. As a result, the targeted liposomes avoid off target effects which is a side effect of many anti-cancer therapies.
特徴および利点
- A ready-to-use lipid blend for the synthesis of PEG-RGD targeted liposomes.
- Step-by-step protocols (extrusion, microfluidics) developed and tested by our formulation scientists.
- Flexible synthesis tool to create uniform and reproducible liposomes.
- RGD ligand enables targeted drug delivery
- A lipid film hydration and extrusion protocol
- A microfluidics protocol using commercial platforms or syringe pumps
For more information, please refer to the protocol under the Protocol section of this page.
法的情報
NanoFabTx is a trademark of Sigma-Aldrich Co. LLC
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
保管分類コード
10 - Combustible liquids
WGK
WGK 3
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
934194-100MG-PW:
934194-25MG:
934194-100MG:
934194-BULK:
934194-VAR:
934194-25MG-PW:
最新バージョンのいずれかを選択してください：
RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer
Wang F, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society, 196, 222-233 (2014)
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
Sheikh A, et al.
Frontiers in Pharmacology, 12, 803304-803304 (2022)
Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
Chen CW, et al.
International journal of nanomedicine, 6, 2567-2580 (2011)
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
Tang Z, et al.
Drug design, development and therapy, 13, 3281-3290 (2019)
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）